training in London. In 2012 Mariam was awarded a Cancer Research UK Clinical Research Fellowship at UCL to complete her PhD studies in the field of chromosomal instability and intratumour heterogeneity. Alongside Professor Charles Swanton she helped set-up the UK-wide CRUK studies TRACERx (TRAcking Cancer Evolution through therapy (Rx)) and PEACE (Posthumous Evaluation of Advanced Cancer Environment). As an NIHR Clinical Lecturer she combines her laboratory and clinical research at the UCL Cancer Institute with her clinical training in Medical Oncology at UCLH. Her research interests include the tracking of tumour evolution through longitudinal tissue and circulating biomarker sampling, and determining the impact of intratumour heterogeneity on therapeutic response and clinical outcomes.

Dr Matt Hellman

Title: Speaker

Country: USA

Organisation: Memorial Sloan Kettering

Matt Hellmann received a BA from the University of Pennsylvania,his MD from Johns Hopkins University, and completed internship and residency training in Internal Medicine at the Massachusetts General Hospital. He then completed his medical oncology fellowship training at Memorial Sloan Kettering Cancer Center. He is now an Assistant Attending at Memorial Sloan Kettering, and specializes in the care of patients with lung cancers. His research focuses on identifying the predictors of response to immunotherapies and developing innovative and effective new ways to harness the body’s immune system to fight cancer.

Dr Pamela Ohashi

Title: Speaker

Country: USA

Organisation: University of Toronto

Dr. Ohashi received her PhD from the University of Toronto with Dr. Tak Mak, and did her post-doctoral training at the University of Zurich with the Nobel Laureate Dr. Zinkernagel, and Dr. Hans Hengartner. She is the co-Director of the Campbell